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Although the somatic cell nuclear transfer (SCNT) technique has been used extensively for cloning and generating transgenic pigs, 
the cloning efficiency is still very low. It has been proposed that the low efficiency of this technique is the result of incomplete 
epigenetic reprogramming and abnormal gene expression during early embryonic development. In this study, we investigate the 
effect of Scriptaid, a low-toxicity histone deacetylase inhibitor, on the developmental competence of porcine SCNT embryos. We 
found that treating SCNT embryos with 500 nmol/L Scriptaid for 15 h after activation significantly enhanced the blastocyst for-
mation rate (27.7%) compared with the untreated group (control) (12.2%, P<0.05). Using an immunofluorescence technique to 
measure the average fluorescence intensity, we also found that treating SCNT embryos with Scriptaid increased the level of his-
tone acetylation on histone H3 at lysine 14 (acH3K14). Furthermore, treating embryos with Scriptaid increased the expression 
level of three genes that play important roles during embryonic development (Oct4, Klf4 at the blastocyst stage and Nanog at the 
4-cell stage). Moreover, the expression level of the apoptosis-related gene Caspase-3 was significantly lower in the Scrip-
taid-treated SCNT embryos compared with the control SCNT embryos at the 4-cell and blastocyst stages. In conclusion, these 
results indicate that Scriptaid treatment improves the development and nuclear reprogramming of porcine SCNT embryos. 
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In 2000, the birth of the world’s first cloned pig using so-
matic cell nuclear transfer (SCNT) created a new range of 
applications for somatic cell-cloned pigs in biomedical re-
search [1,2]. Because of its similarity to humans in terms of 
breeding characteristics and physiology, the pig is consid-
ered an excellent donor for xenotransplantation and has 
been extensively used in human disease models [3]. A low 
cloning efficiency (<1%), however, has restricted the exten-
sive use of porcine SCNT in biomedical research, and it has 
been proposed that this low efficiency is primarily caused 
by inadequate epigenetic reprogramming [4]. Previous stud-
ies have shown that the incomplete reprogramming of SCNT 
embryos results in abnormal gene expression patterns [5]. As 
a consequence of these abnormal expression patterns, the 
cloned embryos may stop developing and be aborted [6]. 
Epigenetic modifications made to the genome include 
genomic methylation and histone modifications [7,8]. His-
tone acetylation can alter chromosome conformation, which 
can increase gene transcription and translation [9]. Histone 
deacetylase inhibitor (HDACi) can increase the acetylation 
level of core histones in cloned bovine embryos [10]. This 
finding demonstrates that HDACi induces hyperacetylation 
and the expression of key genes that are important for 
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SCNT embryonic development. 
Currently, several types of HDACi have been used suc-
cessfully to enhance the nuclear reprogramming of SCNT 
embryos. Valproic acid, for example, can significantly im-
prove the epigenetic reprogramming of SCNT embryos in 
vitro [11,12]. After Trichostatin A (TSA) treatment, the 
developmental ability of pre-implantation SCNT embryos is 
enhanced in several species, such as mice [13], cattle [14] 
and pigs [15]. These findings demonstrate that TSA can 
improve cloning efficiency, but TSA treatments at higher 
concentrations or over longer durations can have harmful 
effects on SCNT embryonic development in vitro and may 
cause developmental defects [16,17]. Scriptaid is a synthetic 
HDACi that induces histone acetylation and chromosome 
remodeling and enhances gene transcription [18]. A previ-
ous study has shown that the development of cloned inbred 
mouse embryos improved significantly in vitro and in vivo 
after Scriptaid treatment and that nascent mRNA expression 
levels were higher in the treated group compared with the 
control groups [19]. Furthermore, treating porcine SCNT 
embryos with Scriptaid also improved their in vitro devel-
opmental capability and their nuclear reprogramming 
[16,20]. Similar results were also obtained in bovine em-
bryos [21]. 
Previous studies have shown that Scriptaid has a positive 
effect on the in vitro and in vivo development of porcine 
embryos, but its underlying mechanism remains to be elu-
cidated. For instance, the effect of Scriptaid treatment on 
gene expression remains unknown. In the present study, we 
aimed to determine the optimal concentration of Scriptaid 
for treatment. We also investigated the relationship among 
histone acetylation (acH3K14), pluripotent gene expression 
(Oct4, Sox2, Klf4 and Nanog), apoptosis-related gene 
expression (Bcl-xl, Caspase-3 and Bak) and Scriptaid 
treatment at different early developmental stages in porcine 
SCNT embryos. We investigate whether treating embryos 
with Scriptaid can change the expression levels of these 
genes and make them similar to the expression levels ob-
served in the conventional in vitro fertilized (IVF) embryos. 
1  Materials and methods 
All of the chemicals used in this study were purchased from 
the Sigma Chemical Company (St Louis, MO, USA) unless 
otherwise noted. All of the solutions and media mentioned 
were filtered through a 0.22-µm filter. All of the animal 
experiments were approved by the Animal Care and Use 
Committee of Jilin University and performed in accordance 
with the Animal Welfare and Ethics Guidelines. 
1.1  Establishment of donor cell 
All of the pigs used in this study were from the Jilin Uni-
versity swine herd. Landrace fetal fibroblast cells (FFCs) 
were used for SCNT and were prepared as previously de-
scribed [22]. First, fetuses were collected from pregnant 
sows at approximately day 35. The head, viscera and limbs 
were removed, and the remaining fetal tissues were cut into 
very fine pieces (1 mm3) with ophthalmic scissors. The tis-
sue pieces were digested with Collagenase IV (200 U/mL) 
and DNase I (25 U/mL) in DMEM containing 20% fetal 
bovine serum for 4–6 h at 39°C with 5% CO2 in the atmos-
phere. Following the digestion, the cell pellet was pooled in 
a 10-cm culture dish and allowed to propagate until conflu-
ent approximately 12 h. The cells were cultured for several 
passages. The cells were frozen and used between passages 
2 and 6 for SCNT. The cultured cells were separated into 
single cells using a trypsin digestion and used as donor cells 
0.5 h before performing SCNT.  
1.2  Preparation of SCNT embryos 
For the preparation of SCNT embryos, a slightly modified 
version of a previously described protocol was used [22]. 
Pig ovaries were obtained from local slaughter houses and 
transported to the laboratory in sterile 0.9% NaCl solution 
with antibiotics at 32–37°C within 4 h. Follicles with a di-
ameter of 3–6 mm were selected, and the cumulus oocyte 
complexes (COCs) were collected by aspirating with a sy-
ringe. The COCs with more than three layers of intact cu-
mulus cells were cultured in a 35-mm dish and allowed to 
mature for 42–44 h at 39°C in a 5% CO2 atmosphere. After 
maturation, the cumulus cells were removed from the COCs 
in 1% PVA-TL-Hepes containing 0.1% hyaluronidase by 
pipetting repeatedly. The matured oocytes with protruding 
first polar body (PB) and a substantial cytoplasm were se-
lected for the production of SCNT or IVF embryos. Meta-
phase II (MII) oocytes were transferred into manipulation 
medium (25 mmol/L Hepes-buffered TCM-199 with 3 
mg/mL BSA) with 0.75 mg/mL cytochalasin B. The PB 
along with a small amount of surrounding cytoplasm, was 
aspirated using a beveled glass pipette to enucleate the oo-
cyte. After enucleation, the donor cell was transferred by 
injecting a single fetal fibroblast cell into the perivitelline 
space closest to cytoplasm of the recipient oocyte. Finally, 
groups of 20 reconstructed complexes were fused and acti-
vated with 2 direct current pulses (1 s interval) of 1.2 kV/cm 
for 30 µs using a BTX ECM 2001 Electro Cell Manipulator 
(BTX, San Diego, CA, USA) in fusion groove. The suc-
cessfully reconstructed embryos were kept in Porcine  
Zygote Medium-3 (PZM3, pH 7.3) supplemented with    
3 mg/mL BSA at 39°C and in a 5% CO2 atmosphere. The 2- 
and 4-cell cleavage rates and the blastocyst formation rate 
were recorded at 24, 48 and 144 h, respectively, with the 
activation time designated as 0 h.  
1.3  In vitro fertilization 
For the preparation of IVF embryos, a slightly modified 
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version of a previously described protocol was used [23]. 
Mature oocytes without cumulus cells were washed three 
times in mTBM medium containing 1 mmol/L caffeine. 
Groups of 40 oocytes were cultured in 100 µL drops of 
mTBM medium and equilibrated for 30 min. The sperma-
tozoa were washed three times in PBS with 0.1% BSA by 
centrifugation at 900×g for 5 min, and then re-suspended in 
mTBM medium. The sperm samples were added to fertili-
zation drops containing the oocytes for a final sperm con-
centration of 5×105 cells/mL, and the oocytes were co-  
cultured with the spermatozoa in mTBM for 5 h. Finally, 
the zygotes were washed three times, and groups of 50 zy-
gotes were cultured in 100 µL of PZM3 medium drops at 
39°C in a 5% CO2 atmosphere. 
1.4  Scriptaid treatment 
Scriptaid was dissolved in dimethyl sulfoxide and prepared 
as a 1000× stock solution at 500 µmol/L. The stock solution 
was stored under dark conditions and added to PZM3 cul-
ture media at different concentrations using serial gradient 
dilutions. Any remaining stock solutions were stored at 4°C 
for no more than 2 weeks. To determine the optimal con-
centration for treatment, the porcine embryos were treated 
with 0, 300, 400, 500, 600, 700, 800 and 1000 nmol/L 
Scriptaid for 15 h after activation. To determine the optimal 
treatment duration, the porcine embryos were cultured with 
500 nmol/L Scriptaid for 0, 8, 15, 24 and 48 h after activa-
tion. After Scriptaid treatment, the culture medium was 
changed to PZM3 without Scriptaid. 
1.5  Detection of acH3K14 and Oct4 using  
immunofluorescence 
Histone acetylation and Oct4 expression levels were deter-
mined using indirect immunofluorescence. The Scrip-
taid-treated and non-treated embryos were collected at the 
2-cell (24 h), 4-cell (48 h) and blastocyst (144 h) stages. 
Embryos were fixed for 30 min in 4% (w/v) paraformalde-
hyde, permeabilized for 30 min with 0.2% Triton X-100 in 
PBS, and then blocked in 5% goat serum in PBS for 30 min 
at room temperature. Next, the embryos were incubated in a 
rabbit polyclonal antibody to histone H3 acetyl K14 
(Abcam, Cambridge, UK) diluted 1:50 or a rabbit polyclo-
nal antibody to Oct-3/4 (H-134) (Santa Cruz Biotechnology, 
CA, USA) diluted 1:200 overnight at 4°C. After washing 
extensively with 0.2% Tween-20 in PBS, the embryos were 
then incubated in an Alexa Fluor-594-labeled goat anti- 
rabbit IgG (Invitrogen, Carlsbad, CA, USA) diluted 1:800 
for 1 h at 39°C. The embryos were mounted on slides in 
mounting medium containing 10 µg/mL Hoechst 33342 to 
stain DNA for 2 min. Images were captured using a fluo-
rescent microscope (Nikon, Japan) and the appropriate ex-
citation wavelength and exposure times. The images of the 
embryos were analyzed using the Image Pro Plus 6.0 soft-
ware (Media Cybernetics, USA). The average ratios of the 
acH3K14 and Oct4 signals were calculated and compared 
among the different groups. To diminish any errors in the 
fluorescence measurements, each experiment was repeated 
at least three times with 10–20 embryos in each replication. 
1.6  Preparation of single-embryo cDNA and real-time 
PCR 
The single cell RNA-Seq method has been previously de-
scribed in detail [24]. In this study, we used a slightly modi-
fied version of this method to prepare single-embryo cDNA. 
Briefly, the zona pellucida was removed at the 2-, 4-cell and 
blastocysts stages from Scritptaid treated, untreated and IVF 
embryos by incubating the embryos in acidic Tyrode’s solu-
tion for 1 min. First-strand cDNA was synthesized using 
SuperScript III reverse transcriptase (Invitrogen) and UP1 
primer. The second strand was amplified using TaKaRa Ex 
Taq™ HS DNA Polymerase (TaKaRa Bio, Japan) and UP2 
Primer. The cDNA was amplified by 20 cycles of PCR. For 
each group, we analyzed three embryos that were randomly 
selected from the same batch at each stage. The cDNA from 
the embryos was diluted ten-fold in nuclease-free water and 
used as the template for real-time PCR. Real-time PCR was 
performed using the BioEasy SYBR Green I Real Time 
PCR Kit (Bioer, Hangzhou, China) on the iQ™5 system 
(Bio-Rad, USA). All PCR reactions were performed in trip-
licate. All of the PCR amplification was performed using 
the following protocol: 94°C for 10 s, then 54/60°C for 15 s, 
and extension at 72°C for 30 s for 40 cycles. The sequences 
of the primers for each assayed gene are shown in Table 1.  
1.7  Counting nuclei of blastocysts and statistical  
analysis 
Blastocysts with good morphology at day 6 were selected 
and fixed in 4% paraformaldehyde in PBS for 30 min at 
room temperature. The embryos were mounted on slides in 
mounting medium containing 10 µg/mL of Hoechst 33342. 
The number of cells in each blastocyst was determined us-
ing a fluorescent microscope with UV light. All of the em-
bryos were collected at random from each treatment group, 
and each analysis was conducted at least three times. The 
cleavage rate data were analyzed using the Chi-Square test. 
Other data were analyzed by one-way ANOVA with SPSS 
16.0 (SPSS Inc., Chicago, IL, USA). P<0.05 was consid-
ered to be statistically significantly different. 
2  Results 
2.1  Scriptaid effect on the development of SCNT  
embryos in vitro 
After activation, SCNT embryos were treated with Scriptaid 
at a concentration of 0 (control), 300, 400, 500, 600, 700,  
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Table 1  Real-time PCR primers and PCR conditions 
Gene Primer sequences (5′→3′) Annealing temperature (°C) Product length (bp) Accession number 
Oct4 F: AAGCAGTGACTATTCGCAAC 
R: CAGGGTGGTGAAGTGAGG 
60 136 NM_001113060.1 
Sox2 F: CGCAGACCTACATGAACG 
R: TCGGACTTGACCACTGAG 
60 103 NM_001123197.1 
Klf4 F: GTTCTCATCTCAAGGCACACC 
R: TCGCACTTCTGGCACTGG 
60 157 NM_001031782.1 
Nanog F: TCCTCTTCCTTCCTCCAT 
R: TCCTTCTCTGTGCTCTTC 
60 108 NM_001129971.1 
β-actin F: GAACCCCAAAGCCAACCGT 
R: CCTCGTAGATGGGCACCGT 
60 173 U07786.1 
Bcl-xl F: TTTTCTCCTTCGGTGGGG 
R: GCATTGTTTCCGTAGAGTTCC 
54 169 NM_214285.1 
Caspase-3 F: GAAGACCATAGCAAAAGGAGCA 
R: TTTGGGTTTGCCAGTTAGAGTT 
54 156 NM_214131.1 
Bak F: TACCTTACCCTGGGAGTGGC 
R: GGAAAACCTCCTCCGTGTC 
54 205 XM_001928147.2 
GAPDH F: GCCATCACCATCTTCCAGG 
R: TCACGCCCATCACAAACAT 
54 190 NM_001206359.1 
 
 
800 and 1000 nmol/L in PZM3 for 15 h. The 2- and 4-cell 
cleavage rates and the blastocyst formation rate were deter-
mined at 24, 48 and 144 h, respectively, and are shown in 
Table 2. The blastocyst formation rate significantly in-
creased when SCNT embryos were treated with 300, 400, 
500 and 600 nmol/L Scriptaid compared with the control 
group (20.7%, 22.1%, 27.7%, 23.5% vs. 12.2%, P<0.05). 
The total cell number of the blastocysts and their cleavage 
rate when treated with different concentrations of Scriptaid 
were not significantly different compared with the non- 
treated embryos. Based on these results, all of the following 
experiments were conducted using 500 nmol/L Scriptaid for 
15 h after activation. 
To better investigate the effects of Scriptaid, we analyzed 
the in vitro development of SCNT embryos treated with 500 
nmol/L Scriptaid for 0, 8, 15, 24 and 48 h. As shown in Ta-
ble 3, the blastocyst formation rate of SCNT embryos treat-
ed with 500 nmol/L Scriptaid for 15 h (28.1%) was higher 
than the rates for embryos treated for 8, 24 or 48 h and for 
the non-treated embryos (19.6%, 17.5%, 18.7% and 14.0%). 
Increasing the treatment duration, however, slightly de-
creased the 2- and 4-cell cleavage rates and blastocyst for-
mation rate of SCNT embryos. The different Scriptaid 
treatment duration did not have any significant effect on the 
average number of cells within the blastocysts.  
2.2  Scriptaid effect on histone acetylation 
To determine the level of the histone acetylation in SCNT 
embryos treated with 500 nmol/L Scriptaid for 15 h,     
the intensity of the epigenetic marker acH3K14 was meas-
ured at the 2-cell, 4-cell and blastocyst stages of Scrip-
taid-treated and control SCNT embryos. As shown in Figure 
1, the average optical intensity of the fluorescence signal for 
acH3K14 increased in SCNT embryos treated with Scriptaid 
at 2-cell (0.048 vs. 0.029), 4-cell (0.055 vs. 0.043), and blas-
tocyst stages (0.033 vs. 0.023), compared with control em-
bryos. 
Table 2  Effects of different Scriptaid concentration on the development of SCNT Embryos in vitro a) 
Concentration of 
Scriptaid (nmol/L) 
No. of  
embryos 
Replications 
No. of cleaved embryos (%) 
at 24 h 
No. of cleaved embryos (%) 
at 48 h 
No. of blastocysts (%)  
at 144 h 
Total cell No. in 
blastocyst 
0 (control) 98 4 58 (59.2) 78 (79.6) 12 (12.2)a 39.5±6.8a 
300 116 4 71 (61.2) 103 (88.7) 24 (20.7)b 35.4±4.5a 
400 95 4 58 (60.1) 77 (81.1) 21 (22.1)b 36.2±3.1a 
500 90 4 58 (64.4) 77 (85.5) 25 (27.7)b 37.6±4.9a 
600 89 4 60 (67.4) 73 (82.0) 21 (23.5)b 39.2±4.1a 
700 131 4 78 (59.5) 103 (78.6) 25 (19.1)ab 35.8±2.6a 
800 71 4 42 (59.1) 58 (81.7) 13 (18.3)ab 34.2±2.3a 
1000 118 4 68 (57.6) 92 (77.9) 17 (14.4)a 35.4±4.5a 
a) a, b values with different superscripts within each column are significantly different (P<0.05); cell number in blastocyst: mean ± SD. 
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No. of cleaved embryos (%) 
at 24 h 
No. of cleaved embryos (%) 
at 48 h 
No. of blastocysts (%) 
at 144 h 
Total cell No. in 
blastocyst 
0 100 4 54 (54.0) 75 (75.0) 14 (14.0)a 36.2± 2.4a 
8 158 3 88 (55.7) 131 (82.9) 31 (19.6)b 38.3± 6.4a 
15 110 4 67 (60.1) 86 (78.1) 31 (28.1)b 37.8± 4.1a 
24 107 4 63 (58.5) 87 (81.3) 19 (17.5)ab 37.2± 5.4a 
48 80 4 42 (52.5) 61 (76.2) 15 (18.7)ab 36.4± 4.9a 




Figure 1  Histone acetylation level, as measured by acH3K14 staining, in SCNT and S-SCNT embryos at the 2-cell (A, D), 4-cell (B, E) and blastocyst (C, 
F) stages. The embryos were labeled with acH3K14 (red) and with Hoechst 33342 for DNA (blue). SCNT, non-treated embryos; S-SCNT, Scriptaid-treated 
embryos. n=15−20. a, b superscripts denote significant differences between SCNT and S-SCNT (P<0.05). 
2.3  Scriptaid effect on the expression of pluripotency- 
related genes and apoptosis-related genes 
To investigate the effects of Scriptaid treatment on gene 
expression patterns during early embryonic development, 
the expression levels of four pluripotency-related genes 
(Oct4, Sox2, Klf4 and Nanog) and three apoptosis-related 
genes (Bcl-xl, Caspase-3 and Bak) were determined in 
Scriptaid-treated SCNT embryos, non-treated SCNT em-
bryos, and IVF embryos at the 2-, 4-cell and blastocyst 
stages. 
As shown in Figure 2, the expression levels of the four 
pluripotency-related genes steadily increased from the 2-cell 
to blastocyst stage. The expression levels of Oct4, Sox2 and  
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Figure 2  The relative expression patterns of Oct4 (A), Sox2 (B), Klf4 (C) and Nanog (D) at the 2-cell, 4-cell and blastocyst stages in IVF, SCNT, and 
S-SCNT embryos during pre-implantation development. IVF, in vitro fertilization; SCNT, non-treated embryos; S-SCNT, Scriptaid-treated embryos. a, b, c 
values with different superscripts are significantly different (P<0.05). 
Klf4 in the SCNT blastocysts were lower than the expres-
sion levels observed in the IVF embryos. The expression 
levels of Oct4 and Klf4 were higher in the Scriptaid-treated 
group at the blastocyst stage compared with the non-treated 
groups (no significant difference in Sox2 expression). Nota-
bly, the expression level of Oct4 at the blastocyst stage in 
the Scriptaid-treated group was similar to the expression 
level observed in the IVF embryos. The expression level of  
Nanog at the 2-cell stage was barely detectable. At the 
blastocyst stage, the expression level of Nanog was similar 
in the Scriptaid-treated and non-treated groups, but at the 
4-cell stage, the expression level of Nanog was significantly 
higher in the Scriptaid-treated SCNT embryos compared 
with the untreated embryos. 
Next, we further investigated the gene expression pattern 
changes that were observed in the SCNT embryos treated 
with Scriptaid. Using real-time PCR, our study shows that 
Scriptaid treatment can restore the Oct4 expression level to 
the level observed in IVF embryos at the blastocyst stage. 
Therefore, we therefore further investigated the Oct4 ex-
pression pattern at the blastocyst stage using immunofluo-
rescence, and the results are shown in Figure 3. The protein 
expression level of Oct4 at the blastocyst stage was higher 
in the Scriptaid-treated embryos compared with the un-
treated groups (0.053 vs. 0.039, P< 0.05). 
We also determined the expression levels of apopto-
sis-related genes (Bcl-xl, Caspase-3 and Bak) at different 
developmental stages. As shown in Figure 4, the expression 
level of Bcl-xl gradually decreased from the 2-cell to 
 
Figure 3  The expression of Oct4 at the blastocyst stage in SCNT and 
S-SCNT embryos determined by indirect immunofluorescence. (A) Images 
of SCNT and S-SCNT embryos at the blastocyst stage. (B) Comparison of 
Oct4 expression between SCNT and S-SCNT embryos. SCNT, non-treated 
embryos; S-SCNT, Scriptaid-treated embryos. n=15– 20. a, b superscripts 
denote significant differences between SCNT and S-SCNT embryos 
(P<0.05). 
blastocyst stage, and the expression levels of Caspase-3 and 
Bak increased from the 2-cell to blastocyst stage. The ex-
pression level of Bcl-xl in the SCNT group was lower than  
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Figure 4  The relative expression patterns of Bcl-xl (A), Caspase-3 (B) and Bak (C) at the 2-cell, 4-cell and blastocyst stages in IVF, SCNT, and S-SCNT 
embryos during pre-implantation development. IVF, in vitro fertilization; SCNT, non-treated embryos; S-SCNT, Scriptaid-treated embryos. a, b values with 
different superscripts are significantly different ( P<0.05). 
the expression level in the IVF and Scriptaid-treated group 
at blastocyst stage. The expression level of Caspase-3 in the 
SCNT group was higher than the expression level in the 
IVF and Scriptaid-treated group at the 4-cell and blastocyst 
stages. Additionally, the expression level of Caspase-3 in 
the Scriptaid-treated embryos was higher than the expres-
sion level in the IVF group. We also found that the expres-
sion level of Bak was similar between the Scriptaid treated 
and untreated SCNT groups.  
3  Discussion 
Recently, a growing body of evidence had indicated that the 
low success rate for cloning and the developmental defects 
found in cloned embryos can be attributed to incomplete 
epigenetic reprogramming, which includes abnormal epi-
genetic modifications, such as DNA methylation and his-
tone modifications, in SCNT embryos [25]. Therefore, we 
used HDAC inhibitors to improve the epigenetic modifica-
tions and increase the developmental competence of SCNT 
embryos.   
In this study, we investigated the effects of Scriptaid on 
the in vitro developmental potential of SCNT embryos. 
When treated with Sciptaid for a longer time period (24,  
48 h), we found that the blastocyst formation rate of the 
embryos was higher than that of the non-treated group. We 
found no significant difference in the 2- and 4-cell cleavage 
rates between these groups. Furthermore, when a higher 
concentration (700, 800 nmol/L) of Scriptaid was used, the 
blastocyst rate was even higher compared to that of the con-
trol group. These findings show that Scriptaid has a lower 
toxicity level in SCNT embryo and are consistent with those 
of previous studies in mice [19]. Furthermore, the in vitro 
developmental capability of SCNT embryos treated with 
Scriptaid improved significantly compared with that of the 
control group. The blastocyst rate was approximately 2-fold 
higher in the Scriptaid-treated group than in the control 
group (27.7% vs. 12.2%). 
Regarding the mechanism underlying the Scriptaid effect 
on the reprogramming of SCNT embryos, histone acetyla-
tion–deacetylation is a dynamic process during embryonic 
development, and increasing histone acetylation relaxes the 
chromosome structure. This relaxed structure may induce a 
transcriptionally permissive state [26,27], which may facili-
tate successful cloning [28]. The key genes for embryonic 
development are more likely to be activated after histone 
hyperacetylation. Studies have shown that treating embryos 
with Scriptaid inhibits histone deacetylase and results in 
hyperacetylation, which can expose DNA active binding 
sites and decrease DNA methylation that are important for 
gene activation [29]. Therefore, gene activation in embryos 
could transform the transcriptional quiescence genome into 
a transcriptional activated state [30].  
H3K14 is an important site for histone acetylation [31]. 
In this study, we found that the average intensity of acetyla-
tion on H3K14 in SCNT embryos increased at the 2-, 4-cell 
and blastocyst stages when the embryos were treated with 
Scriptaid. This result indicates that the level of histone acet-
ylation in the SCNT embryos treated with Scriptaid in-
creased when compared to that in the control group. These 
results are consistent with previous findings for other his-
tone acetylation sites, including H4K5 and H3K9 [21]. 
To determine whether Scriptaid can activate the expres-
sion of pivotal genes through histone acetylation, we exam-
ined the relative mRNA expression levels of four genes that 
play important roles during development, Oct4, Sox2, Klf4 
and Nanog. Oct4 plays a critical role in establishing the 
three cell lineages and in mammalian pre-implantation em-
bryonic development [32]. It is expressed at a significantly 
lower level in SCNT blastocysts compared with IVF blas-
tocysts [33]. Furthermore, Oct4 is initially activated in em-
bryos during the pre-implantation period and can form a 
heterodimer with Sox2, which results in these two proteins 
binding DNA together [34]. Klf4 can activate Nanog 
through the p53 pathway and improve the production of 
induced pluripotent cells. Klf4 is considered a good indica-
tor of pluripotency, and deleting the expression of Klf4 in 
mouse embryos results in early death [35]. Sox2 and Nanog 
are essential transcription factors that maintain the self-  
renewal of undifferentiated embryonic stem cells and estab-
lish embryonic identity. More importantly, previous studies 
have shown that co-expressing Sox2, Oct4 and Nanog can 
form an automatic regulatory network that can establish the 
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porcine embryonic developmental potential [36]. We found 
that treating embryos with Scriptaid significantly increased 
the transcriptional activity of Oct4 and Klf4 at the blastocyst 
stage and Nanog at the 4-cell stage compared with the con-
trol group. Furthermore, the level of Oct4 expression in the 
Scriptaid-treated embryos is similar to the expression level 
observed in IVF embryos. These results indicate that Scrip-
taid can increase the transcriptional activity of genes in 
SCNT embryos and affirm the importance of Oct4, Klf4 and 
Nanog expression during reprogramming. Furthermore, this 
finding also indicates that embryonic gene activation may 
occur at the 4-cell stage in pig embryos. It should be noted 
that the Oct4 expression level in SCNT embryos treated 
with a histone deacetylase inhibitor treatment varies among 
the different studies that have been reported. In bovine 
SCNT embryos treated with Oxamflatin, the Oct4 expres-
sion level was significantly higher than in the IVF group at 
the blastocyst stage [37]. Similar to the finding from the 
present study, porcine embryos treated with TSA appeared 
to have a similar Oct4 expression level compared with IVF 
embryos at the blastocyst stage [38]. The different Oct4 ex-
pression levels observed in embryos treated with a histone 
deacetylase inhibitor may be result of different treatment 
compounds and differing culture condition.  
Apoptosis occurs frequently early embryonic develop-
ment and has a significant impact on the development of the 
embryo [39]. Therefore, we investigated the expression pat-
terns of three apoptosis-related genes, Bcl-xl, Bak and 
Caspase-3. Bcl-xl, which inhibits apoptosis, and Caspase-3 
and Bak, which promote apoptosis, belong to the Bcl-2 fam-
ily. Currently, at least 11 caspase genes have been identified 
that mediate protein cleavage and induce apoptosis. Among 
them, Caspase-3 has been found to execute apoptosis. In 
this study, we found that the expression levels of Caspase-3 
and Bak gradually increased from the 2-cell to the blasto-
cyst stage of embryonic development. After treating em-
bryos with Scriptaid, the expression level of Caspase-3 was 
lower than in the non-treated embryos at the 4-cell and 
blastocyst stages. This result indicates that Scriptaid treat-
ment enhances the vitality of the blastocyst. The expression 
level of the apoptosis-inhibiting gene Bcl-xl, however, also 
decreased during early embryonic development. We cannot 
exclude the possibility that the in vitro culture environment 
gradually deteriorated during the culture progress.  
 In conclusion, our study shows that Scriptaid can im-
prove the blastocyst formation rate of SCNT embryos in 
vitro and can change the expression patterns of specific 
genes that are important in early embryonic development. 
These finding suggest that Scriptaid is beneficial for the 
nuclear reprogramming of early porcine SCNT embryos and 
may be a useful reagent for the efficient cloning pig embryos. 
Future studies should investigate whether Scriptaid affects the 
expression of other genes, and determine what additional 
steps are required to improve the remodeling and repro-
gramming of pig embryos. Furthermore, many reports have 
indicated that the use of histone deacetylase inhibitors has 
adverse effects [40−42]. Therefore, further studies should 
also determine whether Scriptaid can be safely used during 
embryo development and whether it has any adverse effects. 
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